QDI Stock Overview
Provides diagnostic testing and services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$142.40 |
| 52 Week High | US$145.75 |
| 52 Week Low | US$114.25 |
| Beta | 0.89 |
| 11 Month Change | 3.94% |
| 3 Month Change | 6.79% |
| 1 Year Change | 14.33% |
| 33 Year Change | 17.30% |
| 5 Year Change | 55.63% |
| Change since IPO | 283.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| QDI | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.0% | -3.5% | -2.2% |
| 1Y | 14.3% | 23.7% | 13.3% |
Return vs Industry: QDI underperformed the German Healthcare industry which returned 24.7% over the past year.
Return vs Market: QDI matched the German Market which returned 13.6% over the past year.
Price Volatility
| QDI volatility | |
|---|---|
| QDI Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: QDI has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: QDI's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 44,000 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| QDI fundamental statistics | |
|---|---|
| Market cap | €15.94b |
| Earnings (TTM) | €770.46m |
| Revenue (TTM) | €8.77b |
20.6x
P/E Ratio1.8x
P/S RatioIs QDI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QDI income statement (TTM) | |
|---|---|
| Revenue | US$9.54b |
| Cost of Revenue | US$6.39b |
| Gross Profit | US$3.15b |
| Other Expenses | US$2.31b |
| Earnings | US$838.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.51 |
| Gross Margin | 32.97% |
| Net Profit Margin | 8.79% |
| Debt/Equity Ratio | 90.3% |
How did QDI perform over the long term?
See historical performance and comparison